Rare Intestinal Cancer Responds to Combined Immune Therapy
A case report in Frontiers in Oncology describes a patient with rare intestinal hepatoid adenocarcinoma who achieved complete remission of ...
A case report in Frontiers in Oncology describes a patient with rare intestinal hepatoid adenocarcinoma who achieved complete remission of ...
A new review maps how nerve, immune and tumor cell interactions drive pancreatic cancer progression, immune evasion, pain and treatment ...
A retrospective study in BMC Cancer found that adding camrelizumab to TACE and apatinib improved response and survival in elderly ...
A review highlights Histone Deacetylase 1 as a promising epigenetic target to address drug resistance and poor prognosis in cholangiocarcinoma.
A multicenter retrospective study of 54 patients found that lorlatinib significantly extended progression-free survival compared to earlier-generation inhibitors in ALK ...
A retrospective cohort of 155 patients with brain metastases found no association between immunotherapy timing relative to stereotactic radiosurgery and ...
A scientific review highlights clinical and preclinical evidence supporting patritumab deruxtecan as an emerging HER3-targeted therapy across diverse breast cancer ...
Researchers reveal that the ubiquitin ligase MKRN1 protects colorectal cancer cells from cuproptosis by targeting the copper transporter SLC31A1 for ...
A narrative review argues that MEK inhibitors have transformed treatment of NF1-associated plexiform neurofibromas, but predominantly partial responses, toxicity, and ...
A new review details how lipid- and polymer-based nanocarriers can be engineered by size, shape, charge, and surface ligands to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine